This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The biotech’s Series D financing round lays the groundwork to bring its lead program into the clinic in mid-2023, as well as support development of the rest of its pipeline of peptide drugs. FogPharma is preclinical, but not for long.
After leading Novartis and Roche through pivotal years in 2023, the CEOs of the Swiss drug giants each netted multimillion-dollar compensation packages. After leading Swiss drug giants Novartis and Roche through pivotal years, their CEOs have each netted multimillion-dollar compensation packages for 2023.
With Novo Nordisk, Eli Lilly and AstraZeneca leading the way, Big Pharma's sales will grow 4% annually through 2030: analysts kdunleavy Mon, 10/02/2023 - 15:19
In a year that started with more than two-thirds of biopharma companies posting | While Novo Nordisk and Eli Lilly continued to be the biopharma industry growth leaders in the fourth quarter of 2023, many other drugmakers also delivered big gains, including Daiichi Sankyo, Amgen, Teva, GSK and Novartis.
Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk and Eli Lilly—overwhelming the market wi | Booming demand for blood sugar-modulating diabetes and obesity drugs became the top trend in the biopharma industry in 2023, with two companies—Novo Nordisk (..)
Ironwood Pharmaceuticals is paying $1 billion to acquire VectivBio, a biotech whose lead program could become a blockbuster treatment for a gastrointestinal disorder. Preliminary Phase 3 data are expected by the end of 2023.
Teva Pharmaceuticals-Walk-In Drive for Costing Analyst/ Inventory Analyst/ Lead Inventory On 5th Feb’ 2023 A Teva Company), TICEL Bio Park, Taramani Road, Taramani, Chennai 600113 Kindly share your Profile to subhashini.s@teva.com.in
INTERPHEX 2023 is right around the corner, taking place April 25-27 at the Javits Center in NYC. INTERPHEX is set to bring leading brands and professionals together once again with new features, a reimagined Show Floor and returning Show Floor favourites. LB Bohle LLC Korber Pharma North America Syntegon Pharma Technology, Inc.
Environmental Champions: Individuals or teams who are leading environmental or sustainability efforts within their organization or even outside of their day jobs. Read more Digital Crusaders ELITE 2023 Digital Crusader Don Abramo of Pharming Healthcare Inc. Transformational Leaders: People who change the way companies operate.
And in 2023, these investments will hopefully pay off. Leading companies will empower their teams to act quickly, compliantly, and with a unified view of the HCP.”. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes.
Results from CPhI’s 2022 Pharma Index survey , announced at this year’s CPhI Frankfurt, showed pharma confidence in growth , innovation and manufacturing quality has reached record highs, promising positive prospects for the industry in 2023 and beyond. Key countries. Scores this year were the highest on record ( Figure 2 ).
Reassess ahead of 2023. Q4 is all about company budgets so employers will be looking to get new starters over the line before 2023, which means competing with others and streamlining processes to make sure they secure the talent they’re after. Sarah echoes this for pharma, saying: “The pharma space is evolving massively.
Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. In pharma R&D, this could look like a computational biologist collaborating closely with an experimental immunologist, or when AI modellers engage with clinical scientists to refine real-world use cases.
The Pistoia Alliance has launched its Pharma Innovation Council. EMA launches quality control group to aid medicine innovation… The post Pistoia Alliance launches Pharma Innovation Council appeared first on European Pharmaceutical Review. It will be made up of 13 leaders from large global pharmaceutical companies.
MANUFACTURING Continuous direct compression: opening up faster access to oral dose medication Deborah McElhone, CPI’s Medicines Manufacturing Innovation Centre IN-DEPTH FOCUS: QA/QC MICROBIOLOGY Bioburden and sterility testing: how to conserve gene therapy product Kathy Zagaroli, Senior Director of Quality Control at Kiniksa Pharmaceuticals Tom Bujold, (..)
Intas Pharmaceuticals Ltd-Walk-In Interviews for IPQA/ QA/ AQA On 18th Feb’ 2023 Job Description Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. HHPLC and others along with exposure of softwares like Chromeleon and LIMS.
Attending the Reuters Pharma Marketing 2023 event on March 28-29 was a fascinating experience as the pharma marketing industry continues to return to in-person events. We also saw the addition of a track focused on Cell and Gene Therapy, as Pharma ventures into the commercialization of therapeutics.
Novick Biosciences- Walk-In Interview for FRD/ Analytical On 14th to 30th Jan’ 2023. Walk-In Interview for FRD/ Analytical On 14th to 30th Jan’ 2023 @ Novick Biosciences. Designation: Research Associate/ HOD/ Team Lead. Date : 14th to 30th Jan’ 2023. Job Description. Department: FRD/ Analytical.
Todd Somsel , Commercial Lead, RWD Marketplace As I reflect on the 2023 edition of the Reuters Pharma conference in Philadelphia last week, I continue to be motivated by the excitement behind the many uses of real-world data (RWD) and the large number of data and service providers growing their offerings in this space.
Kekule Pharma Limited-Walk-Ins for Production/ R&D/ QC/ Regulatory Affairs On 25th Feb’ 2023 Job Description Kekule Pharma Limited, A Leading USFDA approved Pharmaceutical Company is looking for Dynamic young Energetic, Creative and talented Candidates for the following positions at our API Unit located in Hyderabad.
Divis Laboratories- Walk-In Freshers -B.Sc/ M.Sc/ M.Pharm/ B.Pharm/ B.Tech On 15th to 18th March 2023 Job Description Divis is the leading manufacturer of APIs (Active Pharmaceuticals Ingredients ), Intermediates and Registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 Countries.
Intas Pharmaceuticals Ltd- (45 positions) Walk-In Interviews for Multiple Positions On 5th March 2023 Job Description Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. CM- 14 & 15, Raghuvir Complex, Opp.
Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. Untamed inflation is a top concern for the pharmaceutical industry globally in 2023. Negotiations over these products are expected from October 2023 and run until August 2024.
Hetero Labs Limited-Walk-In Interviews for Production/ EHS/ Engineering- API On 26th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.
-Walk-Ins for Quality Control/ Production/ Production Documentation/ EHS On 7th Jan’ 2023. We are leading API Bulk Drug Manufacturing Company approved by USFDA located near Choutuppal. Walk-Ins for Quality Control/ Production/ Production Documentation/ EHS On 7th Jan’ 2023. Date: 7th Jan’ 2023. Dasami Lab Pvt.
Kekule Pharma Limited-Walk-Ins for Production/ R&D/QC / EHS/ QA On 21st to 23rd Feb’ 2023 Job Description Kekule Pharma Limited, A Leading USFDA approved Pharmaceutical Company is looking for Dynamic young Energetic, Creative and talented Candidates for the following positions at our API Unit located in Hyderabad.
As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control.
Hetero Labs Limited-Walk-In Interviews for Freshers in Production/ QA/ QC/ Maintenance On 5th Mar’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.
Hetero Limited-Campus Interview for B.Sc / M.Sc -Chemistry/ B.Com/ B.Pharm/ ITI Fitter/ Diploma Mechanical On 9th Jan’ 2023. HETERO is one of the India’s leading generic pharmaceutical companies and is one of the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Job Description.
Hetero Labs Limited-Placement Drive for Freshers in Production/ QA QC/ Engineering On 16th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.
Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. Effective April 1, 2023, Naoki Okamura and Kenji Yasukawa will hold the following positions: Naoki Okamura is currently Representative Director, Executive Vice President of Astellas.
The global pharma industry experienced an 11% rise in social media posts on big data in Q1 2023 compared with the previous quarter, with the highest share accounted for Eli Lilly and Co, according to GlobalData’s analysis of social media posts. Buy the report here.
Looking back at 2023 , AI for drug discovery saw both wins and losses. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
Kekule Pharma Limited-Walk-Ins for Production/ R&D/ Regulatory Affairs/ EHS/ QA On On 24th to 28th Jan’ 2023 Job Description Kekule Pharma Limited, A Leading USFDA approved Pharmaceutical Company is looking for Dynamic young Energetic, Creative and talented Candidates for the following positions at our API Unit located in Hyderabad.
Chemistry/ B.Com Freshers On 14th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Chemistry/ B.Com Freshers On 14th Feb’ 2023 Hetero Labs Limited-Campus Placement Drive for B.Sc Chemistry Qualification: B.Sc
Cell and gene therapy industry in 2023 According to data from the GMP Manufacturing Survey, in the past year: “There is an increase in the number of manufacturing organisations and the number of licensed facilities has remained stable. The 2023 data found that the split for bioprocessing roles was 57 percent.
The global pharma industry experienced a 32% rise in social media posts on artificial intelligence in Q1 2023 compared with the previous quarter, with the highest share accounted for Healthcare Information and Management Systems Society, according to GlobalData’s analysis of social media posts.
This alliance dates back to 2021, but in 2023, as Fierce Pharma put it, we “ roared back from rejection to craft a Cannes-winning campaign hospitals couldn’t ignore.” As Cannes put it: “Brands both inside and outside the traditional health and pharma space are adopting a range of creative approaches to help people lead healthier lives.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content